Residents

Navitor Pharmaceuticals

Navitor Pharmaceuticals

A powerful therapeutic approach targeting the central regulator of nutrient signaling, cellular metabolism and growth. New scientific insights are emerging regarding the primal signaling pathways that direct an organism’s metabolic response to conditions in its environment—such as dynamic changes in the availability of nutrients, energy, oxygen and other factors—and the role of these metabolic signaling pathways in disease. Navitor’s drug discovery platform leverages proprietary intellectual property and know-how related to key targets within nutrient signaling pathways and their fundamental role in disease processes. Our proprietary approach targeting nutrient signaling offers an entirely new treatment approach for a broad range of chronic and rare diseases.

Area of focus: 
Cardiovascular and Metabolism
Commencement date: 
12/16/2013

Share